Hot Life Science Investor Mandate 2: PE Plans to Allocate to 5-10 New Biotech, Medtech Targets in 2013 – April 11, 2013

8 Apr

A private equity group based in the Western US has around $100 million in assets, and is currently seeking new investment opportunities in the life sciences space. The firm plans to allocate to around 5-10 companies next year, and typically allocates $1-10 million per firm. The firm is most interested in medtech companies developing medical devices, as well as biotech companies that develop therapeutics.

The firm will only consider firms that currently have products on the market. The firm mainly invests in firms based in the US and Canada, but will also consider firms based in Australia. The firm prefers companies with revenue in the $5-100 million range, and whose enterprise value is less than $100 million. The firm will consider both private & small-cap, publicly owned firms. The firm provides senior secured debt financing to firms and will not take a majority stake in the company.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: